Effect of physician-pharmacist information sharing on blood pressure

Effect of active two-way information sharing between physicians and pharmacists on blood pressure treatment - Effect of active two-way information sharing between physicians and pharmacists on blood pressure treatmen

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049645

Enrollment

Registered

2022-12-01

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

5 months intervention in lifestyle modification (salt reduction, exercise, weight loss, dietary patterns, smoking cessation and sobriety). Residual medication adjustment for 5 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive patients on antihypertensive medication with office blood pressure of 130/80mmHg or higher (with or without comorbidities).

Exclusion criteria

Exclusion criteria: Patients with an office systolic blood pressure >179mmHg and/or diastolic BP >109mmHg.

Design outcomes

Primary

Measure	Time frame
Change in systolic blood pressure at baseline and at the end of the study.	—

Countries

Japan

Contacts

Public ContactTakamasa Iwasawa

Yokosuka General Hospital Uwamachi Cardiology

iwasawat@jadecom.jp046-823-2630

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026